H.R. 1971 · 112th Congress
Pharmacy Competition and Consumer Choice Act of 2011
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 112th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
McMorris RodgersSponsor34 cosponsors · 24 D, 10 R
D
Weiner
MH
D
Hinchey
CP
D
Peterson
MR
D
Ross
HJ
D
Johnson
PW
D
Welch
JC
D
Courtney
LT
R
Terry
RH
D
Hinojosa
JJ
D
Jackson
WJ
R
Jones
DK
D
Kildee
MM
D
Michaud
TM
R
Marino
AS
R
Scott
ET
D
Towns
MF
R
Fitzpatrick
MC
D
Critz
BB
D
Braley
KC
D
Castor
LK
D
Kissell
LD
D
Doggett
JH
R
Herrera Beutler
TY
R
Young
PG
R
Gingrey
GC
D
Connolly
TB
D
Bishop
DB
D
Boren
DS
D
Scott
DL
D
Loebsack
LW
R
Westmoreland
LB
D
Boswell
LB
R
Barletta
TW
D
Walz1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Pharmacy Competition and Consumer Choice Act of 2011 - Amends the Public Health Service Act, the Employee Retirements Income Security Act of 1974 (ERISA), the Internal Revenue Code, and part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to prohibit a group or individual health plan from entering into a…
What it does: CRS summary · Introduced in House · May 24, 2011
Pharmacy Competition and Consumer Choice Act of 2011 - Amends the Public Health Service Act, the Employee Retirements Income Security Act of 1974 (ERISA), the Internal Revenue Code, and part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to prohibit a group or individual health plan from entering into a contract with any pharmacy benefits manager (PBM) to manage the prescription drug coverage provided under such plan or to control the costs of such coverage unless the PBM satisfies the requirements of this Act.
Directs a PBM to provide at least annually a report to each plan sponsor that includes information on the number and total costs of prescriptions under the contract, payments to pharmacies, payments from pharmaceutical manufacturers, and generic drugs and brand name drugs dispensed.
Sets forth provisions governing the interaction between a PBM and pharmacies that contract with the PBM, including requiring a PBM to: (1) include in contracts drug pricing information and agree to provide timely updates on pricing, (2) agree to pay pharmacies promptly for clean claims, (3) not exclude qualifying pharmacies willing to accept terms and conditions of the PBM, and (4) require each pharmacy to sign a contract before assuming responsibility to fill prescriptions for the PBM.
Prohibits a PBM from mandating or providing incentives to beneficiaries for use of a pharmacy in which the PBM has an ownership interest.
Sets forth limits on audits of pharmacy providers by a PBM, including with respect to record keeping, appeals, and recoupment.
Establishes limits and notice requirements related to PBMs selling claims or utilization data.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Pharmacy Competition and Consumer Choice Act of 2011
Latest action (Sep 8, 2011): Referred to the Subcommittee on Health, Employment, Labor, and Pensions.
Policy area: Health · Origin: House · Introduced: May 24, 2011
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.